BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Owolabi BO, Ojo OO, Srinivasan DK, Conlon JM, Flatt PR, Abdel-wahab YHA. Glucoregulatory, endocrine and morphological effects of [P5K]hymenochirin-1B in mice with diet-induced glucose intolerance and insulin resistance. Naunyn-Schmiedeberg's Arch Pharmacol 2016;389:769-81. [DOI: 10.1007/s00210-016-1243-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Conlon JM, Mechkarska M, Abdel-wahab YH, Flatt PR. Peptides from frog skin with potential for development into agents for Type 2 diabetes therapy. Peptides 2018;100:275-81. [DOI: 10.1016/j.peptides.2017.09.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
2 Li Y, Wu M, Chang Q, Zhao X. Stapling strategy enables improvement of antitumor activity and proteolytic stability of host-defense peptide hymenochirin-1B. RSC Adv 2018;8:22268-75. [DOI: 10.1039/c8ra03446j] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
3 Graham GV, Mccloskey A, Abdel-wahab YH, Conlon JM, Flatt PR. A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice. Molecular and Cellular Endocrinology 2020;499:110584. [DOI: 10.1016/j.mce.2019.110584] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Amatya R, Park T, Hwang S, Yang J, Lee Y, Cheong H, Moon C, Kwak HD, Min KA, Shin MC. Drug Delivery Strategies for Enhancing the Therapeutic Efficacy of Toxin-Derived Anti-Diabetic Peptides. Toxins (Basel) 2020;12:E313. [PMID: 32397648 DOI: 10.3390/toxins12050313] [Reference Citation Analysis]
5 Conlon JM, Mechkarska M, Leprince J. Peptidomic analysis in the discovery of therapeutically valuable peptides in amphibian skin secretions. Expert Review of Proteomics 2019;16:897-908. [DOI: 10.1080/14789450.2019.1693894] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Musale V, Moffett RC, Conlon JM, Flatt PR, Abdel-Wahab YH. Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study. Peptides 2021;136:170472. [PMID: 33338546 DOI: 10.1016/j.peptides.2020.170472] [Reference Citation Analysis]
7 Li T, Mo H, Chen W, Li L, Xiao Y, Zhang J, Li X, Lu Y. Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome. Reprod Sci 2017;24:646-55. [PMID: 27613818 DOI: 10.1177/1933719116667606] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
8 Graham GV, Conlon JM, Abdel-Wahab YH, Flatt PR. Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities. Eur J Pharmacol 2020;878:173101. [PMID: 32320703 DOI: 10.1016/j.ejphar.2020.173101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Conlon JM, Moffett RC, Leprince J, Flatt PR. Identification of Components in Frog Skin Secretions with Therapeutic Potential as Antidiabetic Agents. In: Schrader M, Fricker L, editors. Peptidomics. New York: Springer; 2018. pp. 319-33. [DOI: 10.1007/978-1-4939-7537-2_21] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
10 Conlon JM, Musale V, Attoub S, Mangoni ML, Leprince J, Coquet L, Jouenne T, Abdel-Wahab YHA, Flatt PR, Rinaldi AC. Cytotoxic peptides with insulin-releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae). J Pept Sci 2017;23:769-76. [PMID: 28699258 DOI: 10.1002/psc.3025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
11 Carta P, Conlon JM, Scorciapino MA. Conformational change following conversion of inactive rhinophrynin-33 to bioactive rhinophrynin-27 in the skin of the frog Rhinophrynus dorsalis. Biochimie 2021;181:162-8. [PMID: 33359559 DOI: 10.1016/j.biochi.2020.12.011] [Reference Citation Analysis]
12 Shang W, Yang X, Ju X, Xie Y, Zhang Y, Lee W. Characterization of an insulinotropic peptide from skin secretions of Odorrana andersonii: Insulinotropic Peptide from Skin Secretions of Odorrana andersonii. J Pept Sci 2017;23:707-15. [DOI: 10.1002/psc.3017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]